- 2024-08-20 01:58抑制剂hDHODH-IN-1|hDHODH-IN-1|1173715-42-8|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:58抑制剂hDHODH-IN-1|hDHODH-IN-1|1173715-42-8|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:58抑制剂Heptamidine dimethanesulfonate|Heptamidine dimethanesulfonate|161374-55-6|Adamas life|≥98%（以实测数值为
- 2024-08-20 01:58抑制剂Heptamidine dimethanesulfonate|Heptamidine dimethanesulfonate|161374-55-6|Adamas life|≥98%（以实测数值为
- 2024-08-20 01:58抑制剂HCV-IN-29|HCV-IN-29|1009119-83-8|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:58抑制剂HCV-IN-29|HCV-IN-29|1009119-83-8|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:58抑制剂hDHODH-IN-1|hDHODH-IN-1|1173715-42-8|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 01:58抑制剂HCH6-1|HCH6-1|1435265-06-7|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 01:58抑制剂HCH6-1|HCH6-1|1435265-06-7|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:58抑制剂HCH6-1|HCH6-1|1435265-06-7|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:58抑制剂HCV-IN-29|HCV-IN-29|1009119-83-8|Adamas life|≥98%（以实测数值为准）|BR|100mg
- 2024-08-20 01:57抑制剂HC-030031|HC-030031|349085-38-7|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:57抑制剂hCAII-IN-1|hCAII-IN-1|1807520-24-6|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 01:57抑制剂hCAII-IN-1|hCAII-IN-1|1807520-24-6|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:57抑制剂hCAII-IN-1|hCAII-IN-1|1807520-24-6|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:57抑制剂H3B-120|H3B-120|2194903-42-7|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:57抑制剂H3B-120|H3B-120|2194903-42-7|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:57抑制剂HC-030031|HC-030031|349085-38-7|Adamas life|≥98%（以实测数值为准）|BR|100mg
- 2024-08-20 01:57抑制剂HC-030031|HC-030031|349085-38-7|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:57抑制剂H-1152|H-1152|451462-58-1|Adamas life|≥98%（以实测数值为准）|BR|25mg
